928 results on '"Direskeneli, H."'
Search Results
2. POS0276 ANTICOAGULANT TREATMENT IN ADDITION TO IMMUNOSUPPRESSIVES DECREASES THE RELAPSE RATE IN PULMONARY ARTERIAL INVOLVEMENT OF BEHÇET’S DISEASE
3. AB1293 FREQUENCY AND THE EFFECTS OF SPONDYLOARTHRITIS-SPECTRUM DISORDERS ON THE CLINICAL COURSE AND MANAGEMENT OF TAKAYASU ARTERITIS
4. POS0933 THE FREQUENCY OF AORTIC AND MITRAL VALVE INVOLVEMENT IN PATIENTS WITH TAKAYASU ARTERITIS
5. AB0924 THE EFFECT OF PELVIC PARAMETERS AS A MECHANICAL STRESS FACTOR ON SPINAL RADIOGRAPHIC PROGRESSION IN AXIAL SPONDYLOARTHRITIS: PROSPECTIVE FOLLOW-UP DATA
6. AB1328 IS THERE A NEED FOR ROUTINE IMAGING FOLLOW-UP IN PATIENTS WITH TAKAYASU ARTERITIS?
7. The administration of methotrexate in patients with Still’s disease, “real-life” findings from AIDA Network Still Disease Registry
8. Stress Proteins in Behçet's Disease and Experimental Uveitis
9. AB1494 SEXUAL DYSFUNCTION IN BEHÇET’S DISEASE: IS IT AN OVERLOOKED PROBLEM, ESPECIALLY IN MALE BEHÇET’S PATIENTS?
10. POS0158 INCREASED INTIMA-MEDIA THICKNESS OF COMMON FEMORAL VEIN IN BEHÇET’S DISEASE:A SIGN OF FULL LAYER VENOUS WALL INFLAMMATION
11. POS1552 NO BURN-OUT IN PEDIATRIC-ONSET BEHÇET’S DISEASE PATIENTS DURING ADULTHOOD FOLLOW-UP
12. AB1521 DOES PATIENT POSITION AFFECT COMMON FEMORAL VEIN WALL THICKNESS MEASUREMENT BY DOPPLER ULTRASONOGRAPHY AS A DIAGNOSTIC TEST?
13. POS0355 CLINICAL TRAIT-SPECIFIC GENETIC ANALYSIS IN BEHÇET’S DISEASE IDENTIFIES NOVEL LOCI ASSOCIATED WITH OCULAR AND NEUROLOGICAL INVOLVEMENT
14. AB1509 MUCOCUTANEOUS INVOLVEMENT IS THE MORE FREQUENT REASON FOR IMMUNOSUPPRESSIVE NEED COMPARED TO MAJOR ORGAN INVOLVEMENT IN AN EARLY MALE BEHÇET’S DISEASE PROSPECTIVE COHORT
15. POS0711 DEVELOPMENT OF THE TAKAYASU’S ARTERITIS INTEGRATED DISEASE ACTIVITY INDEX
16. LB0009 EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update
17. AB1475 DOES VEIN WALL THICKNESS HAVE PROGNOSTIC VALUE IN BEHÇET’S DISEASE? A PROSPECTIVE FOLLOW-UP STUDY
18. AB1471 PROSPECTIVE FOLLOW-UP OF THE POST-THROMBOTIC SYNDROME DEVELOPMENT RISK IN PATIENTS WITH VASCULAR BEHÇET’S DISEASE
19. One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
20. A patient-driven registry on Behçet's disease: the AIDA for patients pilot project
21. Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
22. Intestinal Behçet's Disease
23. Fatigue in systemic lupus erythematosus: Association with disease activity, quality of life and psychosocial factors
24. Risk factors for malignancy in systemic sclerosis patients
25. ISBD Basic Research Perspectives : A preliminary 'outline' for basic research workshop studies
26. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes
27. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension: Speckle-tracking echocardiographic study
28. Activation of the JAK/STAT pathway in Behcet’s disease
29. POS1271 THE COURSE AND OUTCOMES OF COVID-19 IN PATIENTS WITH TAKAYASU ARTERITIS: CASE SERIES OF 15 PATIENTS FROM A TERTIARY SINGLE CENTER
30. POS0219 EARLIER AND MORE AGGRESSIVE TREATMENT OF MAJOR ORGAN INVOLVEMENT WITH BIOLOGICS MAY PREVENT RELAPSES OR FURTHER NEW ORGAN INVOLVEMENT IN A SUBGROUP OF BEHÇET’S DISEASE PATIENTS
31. POS0821 CORONARY ARTERIAL INVOLVEMENT CAN BE OBSERVED IN A SIGNIFICANT SUBSET OF TAKAYASU’S ARTERITIS PATIENTS BY CORONARY CT-ANGIOGRAPHY
32. POS1401 PROGNOSTIC VALUE OF COMMON FEMORAL VEIN WALL THICKNESS IN BEHÇET DISEASE: A PROSPECTIVE FOLLOW-UP STUDY
33. AB0639 Common Femoral Vein Thickness Measurement as a diagnostic test in Incomplete Behçet’s Disease
34. POS1370 INCREASED INFERIOR VENA CAVA WALL THICKNESS AS A SIGN OF VENOUS INFLAMMATION IN BEHÇET’S DISEASE
35. POS1369 PULMONARY ARTERY WALL THICKNESS IS INCREASED IN BEHÇET’S DISEASE
36. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis
37. Kawasaki syndrome: the Florentine experience
38. The prevalence of non-vascular pulmonary manifestations in Takayasu’s Arteritis patients: A Retrospective multi-centred Turkish cohort study
39. FMF50: a score for assessing outcome in familial Mediterranean fever
40. POS1486-HPR DAILY ACTIVITY IMPAIRMENT IS MEDIATED BY BOTH ORAL DRYNESS AND ORAL HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME
41. AB0895-HPR A MODERATED MEDIATION ANALYSIS FOR POOR ORAL HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH BEHÇET’S DISEASE
42. AB0888-HPR EULAR SJOGREN’S SYNDROME PATIENT REPORTED INDEX-FATIGUE SCORE AND HADS-DEPRESSION SCORE MEDIATE IDENTITY SCORE OF ILLNESS PERCEPTION QUESTIONNAIRE IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME
43. AB0373 PSYCHOMETRIC PROPERTIES OF OUTCOME MEASUREMENT INSTRUMENTS FOR LARGE VESSEL VASCULITIS: A SYSTEMATIC LITERATURE REVIEW
44. The prevalence of non-vascular pulmonary manifestations in Takayasu's Arteritis patients: A Retrospective multi-centred Turkish cohort study.
45. Poster Session Saturday 14 December - AM: 14/12/2013, 08: 30–12: 30Location: Poster area
46. Club 35 Poster session Friday 13 December: 13/12/2013, 08: 30–18: 00Location: Poster area
47. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
48. ARE THERE ANY DIFFERENCES BETWEEN ADULT-ONSET RHEUMATOID ARTHRITIS PATIENTS AND LATE-ONSET RHEUMATOID ARTHRITIS PATIENTS IN TERMS OF USE OF BIOLOGICAL DRUGS AND DRUG RETENTION RATE? RESULTS FROM THE TURKBIO REGISTRY
49. Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort
50. Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.